Liver X receptors (LXR) are transcription factors known for their role in hepatic cholesterol and lipid metabolism. Though highly expressed in fat, the role of LXR in this tissue is not well characterized. We generated adipose tissue LXRα knock-out (ATaKO) mice and show that these mice gain more weight and fat mass on a high fat diet (HFD) compared to wildtype controls.
INTRODUCTION
Obesity, which is characterized by an excessive increase in adipose tissue mass, is an escalating threat of epidemic proportions (1) , and is highly correlated with a plethora of metabolic disorders (2, 3) . Adipose tissue is a very plastic organ that can expand or contract to accommodate the needs of the organism. In cases of excess energy intake, adipose tissue engages in lipogenesis to store this energy as triglyceride (TG), while in times of inadequate dietary sources it breaks down its reserves through lipolysis to provide substrate for oxidation and ATP synthesis within other tissues (4) . Both lipogenesis and lipolysis are tightly controlled in adipocytes (5) . However, in the obese condition the normal homeostatic balance between lipogenesis and lipolysis is altered due to the excess caloric load (5) . Key hormonal regulatory mechanisms that control the balance between lipogenesis and lipolysis in adipose tissue are disrupted. Obese individuals are less sensitive to the antilipolytic actions of insulin and display an increase in basal lipolytic activity in their white adipose tissue, which results in high circulating levels of free fatty acids (FFAs) (6) . These chronically elevated FFAs have been implicated in the pathogenesis of insulin resistance and type 2 diabetes (7). Thus utilization and/or sequestration of FFAs in WAT before they enter the circulation represent an important protective mechanism.
The break-down of TG into FFA and glycerol in both white (WAT) and brown (BAT) adipose tissues are largely under the control of the sympathetic nervous system (SNS) via catecholamines (8) (9) (10) , and also by cardiac natriuretic peptides (11) . In BAT the liberated FFAs provide not only the substrate for mitochondrial oxidative phosphorylation, they also directly activate the brown adipocyte-specific mitochondrial protonophoric uncoupling protein 1 (UCP1).
by guest, on November 10, 2017 www.jlr.org Downloaded from UCP1 disengages energy stored in the proton gradient from ATP synthesis, resulting in a form of energy wastage known as thermogenesis (10, 12) . The existence of BAT has recently been affirmed in adult humans (13, 14) . In WAT on the other hand, it has been traditionally accepted that most of the FFAs liberated by lipolysis are released into the circulation to provide substrate for the energy requirements of other tissues in the body including muscle, heart and BAT (15, 16) . Recent evidence however, indicates a higher mitochondrial content in WAT than previously believed (17, 18) , suggesting a greater role for white adipocyte mitochondria in the regulation of whole-body physiology (19) . In addition to being released into the circulation and, to a much lesser extent, being re-esterified in situ (20) , a portion of the liberated FFA's undergo mitochondrial oxidation within WAT itself (18, 21, 22) . Although basal levels of FA oxidation in WAT mitochondria are much lower than in BAT and muscle, it nevertheless represents a potentially significant contribution due to the total mass of adipose tissue (18, 23) .
Overall lipid homeostasis in adipose tissue is controlled through fatty acid-or cholesterol-sensitive nuclear hormone receptors. These include PPARs (PPARα, PPARδ, and PPARγ), retinoid X receptors (RXRs), farnesoid X receptor and recent, though limited, evidence has come to suggest that Liver X Receptors (LXRs) are also involved in the regulation of FA metabolism in adipose tissue (24, 25) . LXRα and LXRβ are closely related isoforms (26, 27) .
Cholesterol metabolites, known as oxysterols, are the endogenous LXR ligands (28) , and the roles of LXRs in cholesterol metabolism and transport have been quite extensively studied (29) (30) (31) . In addition, LXRs have also been shown to be involved in regulation of bile acid, triglyceride and glucose homeostasis as well as inflammation and intestinal lipid absorption (32) (33) (34) (35) , with most studies having focused on the role of LXRs in liver, macrophages and intestine (36) . LXRβ is expressed ubiquitously throughout many organs and tissues while LXRα, on the by guest, on November 10, 2017 www.jlr.org Downloaded from other hand, is concentrated in metabolically active tissues such as liver, intestine, macrophages as well as in adipose tissue (37) . LXRα is abundantly expressed in adipocytes (37, 38) , and adipocytes are known to be a major location for nonesterified cholesterol, a source of natural LXRs ligands (39) . Nevertheless, there is still much that is not understood about how expression and activation of this nuclear factor in adipose tissue affects systemic body metabolism.
Previous studies have suggested that LXRα can induce adipocyte lipolysis (40) and FFA oxidation (21) . For example, in murine 3T3-L1 adipocytes and human primary adipocytes, LXR activation led to an increase in basal but not hormone-stimulated lipolysis as measured by glycerol release (40, 41) . Another study showed that administration of the synthetic LXR ligands T0901317 or GW3965 to mice resulted in smaller adipocytes and increased serum free fatty acid and glycerol concentrations, suggesting increased adipocyte lipolysis, although no direct measures were performed (42) . In parallel to a role in lipolysis, the LXR agonist GW3965 was reported to increase FA oxidation in both human and murine white fat cells (21) . Finally, while other studies of LXR in WAT have pointed to LXRα as playing a greater role than the LXRβ isoform (40, 43) , the degree to which LXRα regulates lipid metabolism in adipose tissue, and how it contributes to energy homeostasis has not been determined. For this reason, we generated adipose tissue specific LXRα knock-out (ATaKO) mice. Our findings show that deletion of LXRα from adipose tissue promotes an obesogenic phenotype through impaired lipolytic and oxidative capacity of WAT. thioglycollate (Sigma). Four days after injection, mice were euthanized via CO 2 inhalation.
Peritoneal exudate macrophages were collected by washing the peritoneal cavity twice with 12 ml of ice-cold PBS.
High fat diet studies-At six weeks of age, male ATaKO and control mice were put on a high fat diet (HFD, D12492, 60 kcal% from fat, Research Diets Inc.) for 12 weeks. Body weights were measured weekly; food intake and physical activity were measured using the Comprehensive Laboratory Animal Monitory System (CLAMS). At the end of the dietary intervention, body composition was measured by Time Domain-Nuclear Magnetic Resonance (TD-NMR) using a Minispec LF90II (Bruker, Madison, WI). Total body weight and adipose tissue depot weights were measured. Tissues were collected, snap-frozen in liquid nitrogen, and stored at -80°C until further processing for gene expression and protein analyses. Tissues for histology were fixed in 4% paraformaldehyde.
Treatment of mice with LXR agonist T0901317-Six week-old male AT-WT mice consuming chow diet, and twelve week-old male AT-WT mice consuming HFD received daily i.p. injection of either vehicle (control) or 50 µg of T0901317/g body weight/day for seven days. T0901317 was dissolved in dimethyl sulfoxide (DMSO) (50 mg/ml) and diluted (5:1) with 0.9% saline prior to injection according to prescribed protocols (41, (47) (48) (49) Tris-glycine gradient gels, transferred to nitrocellulose membranes, and probed overnight at 4°C
with specific primary antibodies. Secondary anti-rabbit conjugated with alkaline phosphatase were used for specific protein detection. Image acquisition was performed on a Typhoon FLA9000 variable mode imager and analyzed using ImageQuant TL software.
Cell and tissue respiration measurements-Primary mouse adipocytes were prepared from inguinal adipose tissue as follows (50) . Briefly, inguinal fat pads were dissected from 4-6 week old mice. Each 2 mice were pooled together. The fat pads were finely minced and incubated in a Louis, MO) and penicillin/streptomycin (100 units/ml and 100 µg/ml respectively). The SVF suspension was passed through a 40µm strainer to a 6 cm 2 culture plate and incubated at 37ºC, 5% CO 2 for the rest of the experiment. Media was changed on the second day to DMEM-5%FBS LPL activity assay-Inguinal adipose tissue was collected from AT-WT and ATaKO mice.
Tissues were processed and LPL activity was measured according to the manufacturer protocol (Lipoprotein Lipase Activity Assay kit, #ST-610, Cell Biolabs, San Diego, CA).
Histology-Gonadal and inguinal WAT and liver were isolated from ATaKO and AT-WT mice on HFD and fixed in 4% paraformaldehyde, dehydrated, embedded in paraffin, and sectioned (5-μm thickness). Sections were stained with hematoxylin and eosin and examined under brightfield microscopy with a Nikon 80i. Fat cell size of adipose depots was obtained from perimeter tracings using Image J software (http://rsb.info.nih.gov/ij/).
Statistics-Results are presented as mean ± SEM unless otherwise indicated. Data were analyzed using 2-tailed Student's t test or 1-way ANOVA, followed by post-hoc LSD tests when F was significant. Analysis was performed using SPSS software (SPSS Inc. Chicago, IL). For all analyses, statistical significance was considered at p<0.05. On a chow diet, the two genotypes showed no significant difference in body weight ( Figure 1D) or the weight of individual fat depots ( Figure 1E ). However, on a HFD the ATaKO gained significantly more weight than the AT-WT mice ( Figure 2A ). This difference in body weight between the genotypes was independent of food intake ( Figure 2B ) or physical activity ( Figure   2C ). Instead, while there was a modest increase in lean mass ( Figure 2D ), the major contributor to the weight gain in ATaKO was a large increase in fat mass ( Figure 2E ). We also observed that mice with global deletion of LXRα (LXRα -/-mice) exhibit a similar differential weight gain and body composition on HFD as the ATaKO (Supplemental Figure 1A- this effect is secondary to obesity per se or specific to the genotype, the same ex vivo OCR experiments were performed using adipose tissue from both genotypes on the chow diet. The mice were 6-8 weeks old, an age at which there is no detectable differences in total body weight or adipose tissue weight. As shown in Figure 6B , we again observed significantly lower OCR in the samples from the ATaKO mice compared to AT-WT. Note that this difference in OCR between genotypes was not a result of a difference in mitochondrial content, at least as assessed by measuring mitochondrial specific proteins, COX4 and cytochrome C ( Figure 6C, D) . Since UCP1 transcript levels have been shown by our group and other investigators to be affected by LXR (43, 47), we measured UCP1 mRNA in inguinal adipose tissue from both genotypes. There was a small but non-significant difference in UCP1 expression ( Figure 6E ), suggesting that UCP1 activity is unlikely to be responsible for the reduced OCR capacity in the ATaKO mice.
RESULTS

Mice lacking
T0901317 treatment increases adipose tissue OCR-Since we found that the absence of LXRα
in adipose tissue results in lower oxidation in WAT we wanted to investigate whether direct activation of LXR would have the opposite effect, i.e. result in an increase in basal oxidation in inguinal adipose tissue in vivo. OCR was measured ex vivo in inguinal adipose tissue from mice treated or not with T0901317 for seven days. The T0901317 treated mice had increased OCR compared to the vehicle treated mice ( Figure 7A ). There were no differences in serum glycerol between the two groups ( Figure 7B ), but we did observe a decrease in adipocyte cross-sectional area in both gonadal and inguinal adipose tissue in the T0901317 treated mice compared to the saline control group ( Figure 7C ), suggesting that some of the FFAs may be directly taken up by the adipocyte mitochondria for β-oxidation, as we and others previously discussed (17, 22) . We observed the expected increase in TG accumulation in the livers of the T0901317 treated groups ( Figure 7C ), indicative of LXR activation by the exogenous ligand. The lack of increase in serum glycerol is likely explained by its uptake into liver for this TG synthesis (54) . The LXR target gene SREBP1c ( Figure 7D ) was increased in gonadal and inguinal fat, reflective of LXR activation. Note that UCP1 transcript levels were not different between the two treatment groups ( Figure 7E ). Finally, to assess whether the LXR driven oxidation is LXRα specific, we performed the same T0901317 injections in ATaKO mice and measured OCR using the same protocol. No differences were observed in OCR between T0901317 and vehicle injected ATaKO mice (Supplemental Figure 3) , strongly suggesting that this effect is LXRα-specific.
Primary adipocytes treated with T0901317 increase their OCR in a fatty acid-dependent
manner-We next investigated whether LXR activation by T0901317 leads to increased OCR in primary mouse adipocytes. To test this hypothesis, differentiated primary mouse adipocytes from inguinal adipose tissue were treated with 1µM T0901317 or vehicle for 72 hours. Figure 8A shows that cells treated with T0901317 had a significantly higher baseline OCR compared to vehicle treated cells. When treated with the ATP synthase inhibitor oligomycin, T091317 treated cells still had significantly higher OCR, suggesting there may be more uncoupled respiration. Figure 8B shows that there is no difference in the degree of adipocyte differentiation between the two treatments. Because the maximal respiratory capacity observed with FCCP ( Fig 8A) suggests similar mitochondrial content in the T0901317 and control cells, we independently assessed mitochondrial mass using the fluorescent mitochondrial stain Mitotracker. Figure 8B confirmed that mitochondrial content was the same between the two treatment groups. Finally, UCP1 mRNA levels were not different between the two treatment groups ( Figure 8C ).
Since FAs are fuels for mitochondrial respiration, and LXR affects lipolysis, we measured glycerol in the media of these cells in the last 24 hours of an overall 72 hrs of T0901317 treatment. We saw a significantly higher glycerol levels in the media of treated cells compared to controls ( Figure 8D ). Finally, we wanted to test if the increase in OCR in T0901317 treated cells was driven by the increased release of FA from the TG droplet. We treated the cells with FA-free BSA for 1 hour prior to OCR measurement. Under these conditions, the liberated FAs from lipolysis are directly scavenged by BSA making them unavailable as substrate for mitochondrial respiration. The addition of FA free BSA for 1 hour to T0901317 treated cells lowered the OCR to the levels of non-treated cells ( Figure 8E) . Therefore, the increase in OCR in response to the T0901317 is dependent on FA availability.
DISCUSSION
LXRs were first identified in the liver and found to be receptors for oxysterols (55, 56) . The role of LXRs in hepatic cholesterol and lipid metabolism has been extensively dissected, as well as their role in the control of cholesterol absorption from the gut and in macrophage metabolism and inflammation (24, 26) . However LXRs -LXRα in particular -and their natural endogenous oxysterol ligands, are quite abundant in adipose tissue (37, 38) . Despite this fact the function of LXR in the adipose organ is not very well defined (25) . We found that mice with global deletion of LXRα become significantly more obese on a HFD than wild-type mice. While LXRαβ -/-mice have been shown to be obesity resistant by two independent groups (46, 57), LXRα -/-were as obesity prone to WT mice (58) . The discrepancy between this study can be explained by differences in strain, gender, dietary composition and intervention duration (58) . To better understand the role of LXRα in adipose tissue and how it contributes to this obesity phenotype, we generated adipose tissue-specific LXRα -/-mice (ATaKO). The obesogenic phenotype of global LXRα-null mice was mirrored by that of the adipose tissue specific knockouts. ATaKO mice gained significantly more weight than the controls (AT-WT) on a HFD, largely driven by an increase in fat mass and the adipocytes from the ATaKO WAT depots were significantly larger than the AT-WT.
The extent of TG accumulation in adipocytes is regulated by the balance between lipogenesis and uptake vs. lipolysis and export of the fatty acids and glycerol. LXR's role in hepatic lipogenesis is very well established; in this tissue LXR induces lipid accumulation through stimulation of its target genes, SREBP1c, fatty acid synthase (FAS), stearoyl-CoA (SCD1) and Acyl Co-Carboxylase 1 (ACC1) (48, 59) . In adipose tissue, the story becomes less becoming apparent only at a much older age, which we did not investigate. The obesity phenotype in the ATaKO mice was clearly observed under HFD conditions, and may be a consequence of the combined effects of reduced OCR coupled with impaired βAR signaling to lipolysis. In obesity, regulation of adipose tissue lipolysis is disrupted, resulting in an increase in basal lipolysis due to insulin resistance (64) and dampened hormone-induced lipolysis, including decreases in expression of βARs (6) . While this latter aspect can be observed in obese humans, blunted βAR expression is particularly evident in rodents (65) . Therefore the lack of LXRα in adipose tissue impairs mitochondrial respiration and amplifies the derangements in βAR expression resulting from the HFD that would further foster weight gain.
To complement the studies in the ATaKO mice, we took a separate approach to probe the role of LXR in adipose tissue by administering the LXR agonist T0901317 to mice. Although this treatment was of a more acute nature, in general the findings led to much the same conclusion, showing a role for LXRα in lipolysis and mitochondrial respiration. However, acute activation of LXR with T0901317 ligand did not induce changes in phospho-HSL and βAR expression as seen in the absence of LXRα in the ATaKO mice. Nevertheless, WT mice treated with T0901317 had significantly smaller adipocytes in both the gonadal and inguinal depots, consistent with enhanced TG breakdown (66) . T0901317-treated mice WT also had increased OCR in their adipose tissue compared to the saline controls, while in the ATaKO mice the treatment with T0901317 had no effect on WAT OCR. Although it has been shown that in some instances one LXR specific isoform can repress the effect of the other (67), we cannot rule out at this point that XRβ contributes to the phenotype we are observing. An adipose tissue-specific
LXRβ knock-out model will be helpful in dissecting the role of both isoforms in this tissue.
Nevertheless, our data in ATaKO mice treated with T0901317 suggest a specific role for LXRα on respiration. It will be interesting to explore in greater detail at the molecular level how LXRα regulates mitochondrial function in adipocytes; a question that is beyond the scope of these studies.
LXRs affect FFA oxidation in hepatocytes (68, 69) and myocytes (70) . In addition,
Stenson and colleagues showed that LXR activation with GW3965 stimulated pyruvate dehydrogenase kinase 4 (PDK4) in adipocytes, shifting their substrate utilization from glucose to FFA (21) . Unlike previous studies (41, 71), we were not able to detect any increase in either serum FFA or glycerol levels in our male wild-type mice after T0901317 injections compared to saline controls. This difference may be due to the use of different genders in these experiments and the length of fasting prior to blood collection (41, 42, 71, 72) . Finally, studies in primary mouse adipocytes confirmed our findings in the animal models. Cells treated with T0901317 had higher baseline OCR compared to non-treated cells. The increase in oxidative capacity was not explained by an effect on adipogenesis or mitochondrial biogenesis, since there were no differences in these parameters between the treatment groups. Lipolysis was also higher in T0901317 treated adipocytes as measured by glycerol released. Given that FAs liberated through lipolysis fuel mitochondrial β-oxidation (73), the increase in available FFAs in the T0901317 treated cells would appear to be the driving force behind the increased mitochondrial respiration in these cells, since scavenging them with FFA-free BSA eliminated the increase in OCR.
In summary, previous studies have indicated a role for LXR in lipolysis and FFA oxidation, however our findings show for the first time that the lack of LXRα specifically in the WAT of mice results in increased weight gain and elevated adiposity. Our results establish that there is impairment in adipose tissue adrenergic signaling and HSL phosphorylation in ATaKO mice and decreased FA oxidation, rendering the LXRα deficient mice more prone to obesity. In the face of the obesity epidemics these results, together with previous studies on white adipocyte mitochondria and respiration, would suggest that better understanding of WAT respiration and fuel utilization may allow targeted activation of these pathways in adipose tissue to decrease adiposity and limit circulating serum FFAs. by guest, on November 10, 2017
